Company
Judo
Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new treatments for systemic and renal diseases.
Also known as Judo Bio
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new RNA medicines for systemic and renal diseases.
Funding snapshot
- Total raised
- $100MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $100M2024-10-07
Funding rounds
- Round, 2024
- $100M2024-10-07, Company stated
Loading relationship preview